Tofersen, a new drug approved by the FDA for a genetic form of ALS, delays symptom progression and death and in about one-quarter of participants leads to stabilization or improvement. “Stopping disease progression and making improvements over 3 to 5 years is unheard of in this type of ALS.”

Published 2 hours ago

Source: reddit.com

Tofersen, a new drug approved by the FDA for a genetic form of ALS, delays symptom progression and death and in about one-quarter of participants leads to stabilization or improvement. “Stopping disease progression and making improvements over 3 to 5 years is unheard of in this type of ALS.”

Tofersen, a new drug approved by the FDA for a genetic form of ALS, delays symptom progression and death and in about one-quarter of participants leads to stabilization or improvement. “Stopping disease progression and making improvements over 3 to 5 years is unheard of in this type of ALS.”

submitted by /u/mvea
[link] [comments]

Categories

science

Read Original Article

Related Articles from reddit.com

Even proficient L2 writers coin new words. In 90 essays (~49k words), the study identified 28 lexical deviations; 25 were neologisms—far more than borrowings—consistent with learners relying on word-formation when the intended item isn’t readily accessible.

Amazon Visa Delays Prompt India Remote Work With Strict Restrictions

Ukraine damages major Russian oil assets in New Year's Eve strikes, military reports

A Pennsylvania court says police can sift through Google searches to find suspects

US seeks unpaid local interns at Greenland consulate as annexation threats loom

Rising income inequality predicts longer work hours globally, new research finds. By analyzing data from nearly 70 countries and long-term surveys from the United States and China, the researchers found that widening income gaps tend to predict longer work weeks.